Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017–2018 and 2020–2021 following a WHO Survey

Prevalence of Pretreatment HIV-1 Drug Resistance in Armenia in 2017–2018 and 2020–2021 following a WHO Survey

The increased antiretroviral therapy (ART) coverage of patients in the absence of routine genotyping tests and in the context of active labor migration highlight the importance of HIV-1 drug resistance (DR) surveillance in Armenia. We conducted a two-phase pretreatment DR (PDR) study in 2017–2018 (p...

Full description

Bibliographic Details
Main Authors: Alina Kirichenko, Dmitry Kireev, Ilya Lapovok, Anastasia Shlykova, Alexey Lopatukhin, Anastasia Pokrovskaya, Natalya Ladnaya, Trdat Grigoryan, Arshak Petrosyan, Tatevik Sarhatyan, Narina Sargsyants, Tamara Hovsepyan, Hovsep Ghazaryan, Hermine Hovakimyan, Siranush Martoyan, Vadim Pokrovsky
Format: Article
Language:English
Published: MDPI AG 2022-10-01
Series:Viruses
Subjects:
HIV-1
PDR
drug resistance
EECA
Armenia
Online Access:https://www.mdpi.com/1999-4915/14/11/2320

Similar Items

Similar Items